NIH, NIST researchers use artificial intelligence for quality control of stem cell-derived tissues
14/11/2019
Technique key to scale up manufacturing of therapies from induced pluripotent stem cells.
Technique key to scale up manufacturing of therapies from induced pluripotent stem cells.